National (Australia) HPV 3 dose vaccination coverage for females turning 15 years of age in 2015

State Estimated
Resident
Population
(as at
30/06/2015)		 Coverage Dose 1 Coverage Dose 2 Coverage Dose 3 Total
Doses
n % n % n %
ACT 2,133 2,001 93.8% 1,906 89.4% 1,671 78.3% 5,578
NSW 44,175 39,154 88.6% 37,987 86.0% 35,939 81.4% 113,080
NT 1,492 1,523 102.1% 1,459 97.8% 1,361 91.2% 4,343
QLD 29,463 25,223 85.6% 24,361 82.7% 22,575 76.6% 72,159
SA 9,769 8,364 85.6% 8,040 82.3% 7,339 75.1% 23,743
TAS 3,093 2,693 87.1% 2,515 81.3% 2,196 71.0% 7,404
VIC 34,243 30,350 88.6% 29,220 85.3% 27,105 79.2% 86,675
WA 15,111 12,802 84.7% 12,404 82.1% 11,561 76.5% 36,767
NAT 139,479 122,110 87.5% 117,892 84.5% 109,747 78.7% 349,749


NOTES

  • Data extracted from the National HPV Vaccination Program Register (HPV Register) as at 04 JULY 2018 and includes females vaccinated between APR 2007 and JUN 2018.
  • Includes doses that comply with the recommended vaccine dosage and administration as per the Australian Immunisation Handbook (up to 3 doses administered at prescribed intervals).
  • Population is Estimated Resident Population 2015 (as at 30/06/2015) as provided by the Australian Bureau of Statistics - CAT 3101.0 Australian Demographics Statistics, Tables 51 to 58 - Estimated Resident Population by Single Year of Age by State and Territory, FINAL based on 2016 census data published JUN 2018.
  • Age is age as at date of ERP estimate (30th June).
  • Coverage is calculated as doses administered and reported to the HPV Register/Estimated Resident Population expressed as a percentage.
  • Excludes consumers who do not wish their details to be recorded on the HPV Register.
  • The National HPV Vaccination Program initially provided quadrivalent HPV vaccine for all females aged 12-26 years as at mid 2007 ( school program commenced April 2007 and GP/community program in July 2007) until end December 2009. From 2009 the Program offered HPV vaccination routinely to females in the first year of high school (usually at 12-13 years). From 2013, males were also offered HPV vaccination routinely in the first year of high school (age 12-13 years), with a catch-up program available for males aged 14-15 years in 2013 and 2014.
  • As the ages of students in the first year of high school varies between jurisdictions, age 15 is used as the age for routine review of vaccination coverage that provides the best comparison to allow for these varying ages in administration, as per World Health Organization (WHO) recommendations.
  • HPV Vaccination doses administered through general practice and in other community settings may be incompletely notified to the HPV Register. The extent of under notification differs by jurisdiction, with the Northern Territory and Queensland expected to have the most complete notification, due to notification of doses via State based immunisation registers.